Claims for Patent: 6,042,824

Summary for Patent: 6,042,824

Title:	Methods using cross linked protein crystal formulations as catalysts in organic solvents
Abstract:	The present invention relates to the application of biocatalysis technology for performing selective chemical reactions. In one embodiment, this invention relates to crosslinked protein crystal formulations and their use as catalysts in chemical reactions involving organic solvents. This invention also provides methods for producing crosslinked protein crystal formulations and methods using them to optimize chemical reactions in organic solvents, including those used in industrial scale chemical processes.
Inventor(s):	Khalaf; Nazer K. (Worcester, MA)
Assignee:	Altus Biologics, Inc. (Cambridge, MA)
Application Number:	08/868,088
Patent Claims:	1. A method for using a crosslinked enzyme crystal formulation to produce a selected product in an organic solvent or an aqueous-organic solvent mixture, said method comprising the steps of: (a) combining at least one substrate and at least one crosslinked enzyme crystal formulation which acts upon said substrate in the presence of an organic solvent or an aqueous-organic solvent mixture, said crosslinked enzyme crystal formulation comprising crosslinked enzyme crystals and a surfactant, said crosslinked enzyme crystal formulation being characterized by an enzyme activity in an organic solvent or an aqueous-organic solvent mixture which is at least about 1.7 times greater than the enzyme activity of the equivalent amount of said enzyme in either crude form or pure form; and (b) maintaining the combination produced in step (a) under conditions which permit said enzyme to act upon the substrate, thereby producing said product in said organic solvent or aqueous-organic solvent mixture. 2. A method for using a crosslinked enzyme crystal formulation to produce a selected product in an organic solvent or an aqueous-organic solvent mixture, said method comprising the steps of: (a) combining at least one substrate and at least one crosslinked enzyme crystal formulation which acts upon said substrate in the presence of an organic solvent or an aqueous-organic solvent mixture, said crosslinked enzyme crystal formulation comprising crosslinked enzyme crystals and a surfactant, said crosslinked enzyme crystal formulation being characterized by having at least about 4.3 times greater specific activity per milligram of solid in an organic solvent or an aqueous-organic solvent mixture than that of said enzyme in either crude form or pure form; and (b) maintaining the combination produced in step (a) under conditions which permit said enzyme to act upon the substrate, thereby producing said product in said organic solvent or aqueous-organic solvent mixture. 3. A method for using a crosslinked enzyme crystal formulation to produce a selected product in an organic solvent or an aqueous-organic sol-vent mixture, said method comprising the steps of: (a) combining at least one substrate and at least one crosslinked enzyme crystal formulation which acts upon said substrate in the presence of an organic solvent or an aqueous-organic solvent mixture, said crosslinked enzyme crystal formulation comprising crosslinked enzyme crystals and a surfactant, said crosslinked enzyme crystal formulation being characterized by having at least about 19 times greater enzyme activity in an organic solvent or an aqueous-organic solvent mixture than the activity of crosslinked crystals of said enzyme containing no surfactant; and (b) maintaining the combination produced in step (a) under conditions which permit said enzyme to act upon the substrate, thereby producing said product in said organic solvent or aqueous-organic solvent mixture. 4. The method according to any one of claims 1, 2 or 3, wherein said product is selected from the group consisting of chiral organic molecules, peptides, carbohydrates and lipids. 5. The method according to claim 1, wherein said enzyme is selected from the group consisting of hydrolases, isomerases, lyases, ligases, transferases and oxidoreductases. 6. The method according to claim 5, wherein said enzyme is a hydrolase. 7. The method according to claim 6, wherein said hydrolase is selected from the group consisting of thermolysin, elastase, esterase, lipase, nitrilase, hydantoinase, protease, asparaginase, urease and lysozyme. 8. The method according to any one of claims 1, 2 or 3, wherein said organic solvent is selected from the group consisting of octanes, diols, polyols, polyethers and water soluble polymers. 9. The method according to claim 8, wherein said organic solvent is selected from the group consisting of toluene, octane, tetrahydrofuran, acetone, pyridine, diethylene glycol, 2-methyl-2,4-pentanediol, poly(ethylene glycol), triethylene glycol, 1,4-butanediol, 1,2-butanediol, 2,3,-dimethyl-2,3-butanediol, 1,2-butanediol, dimethyl tartrate, monoalkyl ethers of poly(ethylene glycol), dialkyl ethers of poly(ethylene glycol), and polyvinylpyrrolidone.

Details for Patent 6,042,824

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2016-05-24